Mattheus H E Wildschut
Overview
Explore the profile of Mattheus H E Wildschut including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
118
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wegmann R, Bonilla X, Casanova R, Chevrier S, Coelho R, Esposito C, et al.
Nat Commun
. 2024 Oct;
15(1):9402.
PMID: 39477946
Deep single-cell multi-omic profiling offers a promising approach to understand and overcome drug resistance in relapsed or refractory (rr) acute myeloid leukemia (AML). Here, we combine single-cell ex vivo drug...
2.
Polesel M, Wildschut M, Doucerain C, Kuhn M, Flace A, Sa Zanetti L, et al.
Mitochondrion
. 2024 May;
78:101889.
PMID: 38692382
Iron is a trace element that is critical for most living organisms and plays a key role in a wide variety of metabolic processes. In the mitochondrion, iron is involved...
3.
Wildschut M, Mena J, Dordelmann C, van Oostrum M, Hale B, Settelmeier J, et al.
Nat Commun
. 2023 Oct;
14(1):6414.
PMID: 37828014
Myelofibrosis is a hematopoietic stem cell disorder belonging to the myeloproliferative neoplasms. Myelofibrosis patients frequently carry driver mutations in either JAK2 or Calreticulin (CALR) and have limited therapeutic options. Here,...
4.
Schurch P, Malinovska L, Hleihil M, Losa M, Hofstetter M, Wildschut M, et al.
Cell Rep
. 2022 Nov;
41(8):111689.
PMID: 36417879
Calreticulin (CALR) is an endoplasmic reticulum (ER)-retained chaperone that assists glycoproteins in obtaining their structure. CALR mutations occur in patients with myeloproliferative neoplasms (MPNs), and the ER retention of CALR...
5.
Simonis A, Russkamp N, Mueller J, Wilk C, Wildschut M, Myburgh R, et al.
Blood Adv
. 2021 Mar;
5(5):1273-1277.
PMID: 33651098
No abstract available.
6.
Lysenko V, van Wijk N, Zimmermann K, Weller M, Buhler M, Wildschut M, et al.
Blood Adv
. 2020 Jun;
4(11):2477-2488.
PMID: 32502268
The engraftment potential of myeloproliferative neoplasms in immunodeficient mice is low. We hypothesized that the physiological expression of human cytokines (macrophage colony-stimulating factor, interleukin-3, granulocyte-macrophage colony-stimulating factor, and thrombopoietin) combined...
7.
Struntz N, Chen A, Deutzmann A, Wilson R, Stefan E, Evans H, et al.
Cell Chem Biol
. 2019 Mar;
26(5):711-723.e14.
PMID: 30880155
The transcription factor Max is a basic-helix-loop-helix leucine zipper (bHLHLZ) protein that forms homodimers or interacts with other bHLHLZ proteins, including Myc and Mxd proteins. Among this dynamic network of...
8.
Visscher M, De Henau S, Wildschut M, van Es R, Dhondt I, Michels H, et al.
Cell Rep
. 2016 Sep;
16(11):3041-3051.
PMID: 27626671
The balance between protein synthesis and protein breakdown is a major determinant of protein homeostasis, and loss of protein homeostasis is one of the hallmarks of aging. Here we describe...